The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease

BACKGROUND: Strict glycaemic control in patients with type 2 diabetes has proven to have microvascular benefits while the effects on CVD and mortality are less clear, especially in high risk patients. Whether strict glycaemic control would reduce the risk of future CVD or mortality in patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cardiovasc Diabetol
Autori principali: Bots, Sophie H., van der Graaf, Yolanda, Nathoe, Hendrik M. W., de Borst, Gert Jan, Kappelle, Jaap L., Visseren, Frank L. J., Westerink, Jan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950600/
https://ncbi.nlm.nih.gov/pubmed/27431507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0418-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi